来自Amanita vaginata的新型莱克具有强大的抗炎活性
Thoiba Mogahid Hussein Seliman1, Nurten Ozsoy1, Gulsum Altiparmak-Ulbegi1
1Department of Biochemistry, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
Natural product research
|July 18, 2025
概括
来自Amanita vaginata的新型莱克,名为AVL,显示出显著的抗炎性质. AVL有效地抑制关键的炎症标志物,诱导性氧化合成酶 (iNOS) 和循环氧化酶-2 (COX-2),以剂量依赖的方式.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症是一种复杂的生物反应,与各种疾病有关.
- 鉴定新型抗炎化合物对于治疗开发至关重要.
- 乳清素是具有多种生物活动的蛋白质,包括免疫调节作用.
研究的目的:
- 从Amanita vaginata中净化和表征一种新型莱克 (AVL).
- 为了研究AVL的抗炎潜力.
- 为了阐明AVL抗炎作用的机制.
主要方法:
- 硫酸分量沉和亲和色谱被用于AVL净化.
- 二甲基硫酸盐-聚烯胺凝电泳 (SDS-PAGE) 确定了分子重量.
- 西部斑点分析评估了诱导性氧化合成酶 (iNOS) 和循环氧化酶-2 (COX-2) 在脂多糖 (LPS) 刺激的RAW 264.7巨细胞中的表达.
主要成果:
- 一种莱克 (AVL) 被净化,产量为20%,纯度增加了16倍,在SDS-PAGE.PAGE上显示了一个45kDa的单一带.
- 在LPS刺激的巨细胞中,AVL治疗显著抑制了iNOS和COX-2的表达.
- 观察到AVL的抗炎作用是剂量依赖的.
结论:
- 来自Amanita vaginata的净化莱克AVL表现出显著的抗炎活性.
- 通过抑制iNOS和COX-2表达来促进AVL的抗炎作用.
- 在炎症性疾病中,AVL是潜在的治疗候选者.
关键词:
阿曼尼塔 瓦吉纳塔 阿曼尼塔抗炎药物 抗炎药物 抗炎药物在COX-2中,COX-2是最常见的.染色体学 染色体学 是一种染色学.莱克是一种学菌素.类是一种真菌.RAW 264.7 巨细胞巨细胞我们的 iNOS iNOS更多相关视频
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.6K
10:02Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
2.1K
相关概念视频
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
